Accuray

Rank: 84

2016 Rank91 Employees959 Revenue:$398,800,000 R&D Spend:$56,700,000 Fiscal year ending:06-30-16 Click here to see all 100

Accuray received a Good Design Award 2014 from the Japan Industrial Design Promotion Organization (JDP) for the CyberKnife Robotic Radiosurgery System’s excellence in design.

Accuray Signs Long-Term Strategic Development and Supply Agreement with medPhoton for Volumetric Image Guidance Solutions for the CyberKnife System. Accuray Submits 510(k) Premarket Notification to FDA for Its Radixact™ Treatment Delivery System. MedStar Georgetown University Hospital Treats 1,000 Prostate Cancer Patients with the CyberKnife System. Accuray Closes $70 Million Straight Debt Financing. First CyberKnife® M6™ and TomoTherapy® Systems in Chile Installed at Fundacion Arturo Lopez Perez Cancer Institute. Accuray - Cowealth Arbitration Ruling Delivered. Anova Cancer Care Treats 1,000th Prostate Cancer Patient with the CyberKnife® System. Accuray and RaySearch Announce Second Long-Term Collaboration Agreement. Accuray Awarded Multi-System Order by 21st Century Oncology. Accuray and RaySearch Announce Long-Term Collaboration Agreement Regarding the RayCare® Oncology Information System. Accuray Signs Agreement with MIM Software Inc. to Develop Adaptive Therapy Software. Accuray to Showcase New CyberKnife® and TomoTherapy® Technologies at ESTRO 2015. Accuray Establishes First TomoTherapy® and CyberKnife® System Education Centers in China.

Key Personnel: Joshua Levine, president & CEO; Lionel Hadjadjeba, SVP & CCO; Kevin Waters, SVP & CFO; Darl Moreland, SVP, quality management; Alaleh Nouri, SVP, general counsel; Andy Kirkpatrick, SVP, global operations & R&D;

http://www.accuray.com